IRCT20141006019417N2RecruitingPhase 3
The effect of melatonin on cardiac biomarkers after coronary artery bypass graft (CABG) surger: ?a pilot clinical trial
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 80 years (—)
- Sex
- All
Inclusion Criteria
- •18 to 80 years old patients who are candidates for coronary artery bypass graft;
- •Informed consent to participate in the study.
Exclusion Criteria
- •Taking anticonvulsants - antidepressants drugs;
- •History of coronary artery bypass graft;
- •Emergency Coronary Artery Bypass Grafting;
- •Ejection Fraction ? 30;
- •Severe pulmonary disease;
- •Non-sinus rhythm heart before surgery;
- •Having a pacemaker;
- •Liver disease;
- •Simultaneously valvular heart surgery.
Investigators
Similar Trials
Not yet recruiting
Phase 3
Effects of melatonin on patients after coronary artery bypass surgeryDiseases of the circulatory system.IRCT20111119008129N14Boushehr University of Medical Sciences60
Recruiting
Phase 3
Effect of Melatonin in brain injuryBrain injury.Intracranial injuryIRCT20081208001497N8Esfahan University of Medical Sciences60
Completed
Phase 2
Melatonin and Cardiac Outcome After Major SurgeryAortic AneurysmNCT00315926University Hospital, Gentofte, Copenhagen52
Unknown
Phase 2
Effect of Melatonin on Cardiovascular and Muscle Mass and Function in Patients With Heart FailureHeart Failure With Reduced Ejection FractionNCT03894683Isfahan University of Medical Sciences90
Recruiting
Phase 3
The effect of melatonin in Ulcerative colitislcerative colitis.Ulcerative colitisIRCT20121021011192N9Shahid Beheshti University of Medical Sciences40
